PURPOSE: A single tablet containing a first composition containing rosuvastatin calcium salt and anhydrous dibasic calcium phosphate and a second composition containing fenofibric acid calcium salt is provided to stabilize rosuvastatin calcium salt and sample bioavailability with conventional fenofibrate formulation and rosuvastatin calcium salt formulation. CONSTITUTION: A single tablet for preventing and treating lipid metabolic disorders contains a first composition containing rosuvastatin calcium salt and anhydrous dibasic calcium phosphate and a second composition containing fenofibric acid calcium salt. The second composition contains hydroxyl propyl methyl cellulose and enteric polymers. The enteric polymer is polymethacrylate.본 발명은 로수바스타틴칼슘염 및 무수인산수소칼슘을 함유하는 제1 조성물 및 페노피브린산칼슘염을 함유하는 제2 조성물을 포함하는 지질대사 질환 치료 및 예방용 단일정제를 제공한다.
